Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
America’s Car-Mart ( (CRMT) ) has shared an announcement.
On September 25, 2025, America’s Car-Mart held its annual stockholders meeting, where key decisions were made, including the election of directors for a one-year term and the approval of an advisory resolution on executive compensation. Additionally, the stockholders ratified the selection of Grant Thornton LLP as the independent public accounting firm for the fiscal year ending April 30, 2026. These decisions are crucial for the company’s governance and financial oversight, ensuring continued strategic direction and compliance with industry standards.
The most recent analyst rating on (CRMT) stock is a Hold with a $37.00 price target. To see the full list of analyst forecasts on America’s Car-Mart stock, see the CRMT Stock Forecast page.
Spark’s Take on CRMT Stock
According to Spark, TipRanks’ AI Analyst, CRMT is a Neutral.
America’s Car-Mart’s overall stock score reflects significant financial and technical challenges. The company’s financial performance is hindered by declining profitability and liquidity issues. Technical analysis indicates bearish momentum. While the earnings call provided some positive developments, the overall sentiment remains mixed. Valuation is moderate, but the absence of a dividend yield limits appeal.
To see Spark’s full report on CRMT stock, click here.
More about America’s Car-Mart
America’s Car-Mart, Inc. operates in the automotive retail industry, primarily focusing on the sale of used vehicles. The company is known for its buy here, pay here model, which targets customers with limited or poor credit history, providing them with financing options directly from the dealership.
Average Trading Volume: 134,077
Technical Sentiment Signal: Sell
Current Market Cap: $250.6M
For detailed information about CRMT stock, go to TipRanks’ Stock Analysis page.